Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3366-3374

  Nakamura, K ^a   Niimi, M ^a   Niimi, K ^a   Holmes, A R ^a   Yates, J E ^a   Decottignies, A ^a   Monk, B C ^a   Goffeau, A ^a   Cannon, R D ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMPHOTERICIN B; ANTIFUNGAL AGENT; AUROVERTIN; BENOMYL; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CYCLOHEXIMIDE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MULTIDRUG RESISTANCE PROTEIN; NAFTIFINE; NIGERICIN; NUCLEOSIDE TRIPHOSPHATASE; OLIGOMYCIN; PROTEIN CDR1P; PYRROLE; QUINIDINE; RHODAMINE; TAMOXIFEN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VALINOMYCIN; VERAPAMIL;

ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; DNA SEQUENCE; DRUG TRANSPORT; ENZYME ACTIVITY; GENE LOCUS; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION;

ACID ANHYDRIDE HYDROLASES; ANTIFUNGAL AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CANDIDA ALBICANS; CARRIER PROTEINS; CHROMOSOMES, FUNGAL; CULTURE MEDIA; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; FUNGAL PROTEINS; IMMUNOCHEMISTRY; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; NUCLEOSIDE-TRIPHOSPHATASE; PHENOTYPE; PLASMIDS; SACCHAROMYCES CEREVISIAE;

EID: 0035185602     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3366-3374.2001     Document Type: Article

References (47)

1. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
2. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1
3. Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Drug pumping mechanisms in Candida albicans
6. Molecular cloning and expression of the Candida albicans β-N-acetylglucosaminidase (HEX1) gene
7. Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes
8. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: Possible role for drug efflux in drug resistance
9. Oral Candida in HIV infection and AIDS: New perspectives/new approaches
10. Complete inventory of the yeast ABC proteins
11. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p
12. Solubilization and characterization of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast
13. Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily
14. Fluconazole resistant candida in AIDS
15. Plasma membrane ATPase from the yeast Saccharomyces cerevisiae
16. ABC transporters: From microorganisms to man
17. Flip-flop: The transmembrane translocation of lipids
18. The ABC of channel regulation
19. Ins and outs of antimicrobial resistance: Era of the drug pumps
20. Molecular mechanisms of azole resistance in fungi
21. Candida albicans resistance in AIDS
22. Anticancer drugs, ionophoric peptides, and steroids as substrates of yeast multidrug transporter Pdr5p
23. Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae
24. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: Expression of a yeast multidrug transporter in baculovirus expression system
25. Characterisation of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family
26. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains
27. Fluconazole plus cyclosporine: A fungicidal combination effective against experimental endocarditis due to Candida albicans
28. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
29. +-ATPase from Candida albicans
30. Microbial multidrug-resistance ABC transporters
31. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
32. Phosphatidylcholine translocase: A physiological role for the mfr2 gene
33. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection
34. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
35. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
36. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
37. Application of DNA typing methods to epidemiology and taxonomy of Candida species
38. +-ATPase from Saccharomyces cerevisiae
39. Molecular mechanisms of drug resistance in fungi
40. Mechanisms and clinical impact of antifungal drug resistance
41. MDR1 P-glycoprotein is a lipid translocase of broad specifity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
42. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
43. Antifungal drug resistance in Candida albicans
44. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance